Condition: Dermatitis · Acne · Conditions After Dematosurgical Procedures · Sponsor: Primex ehf
This is a post-marketing observational clinical investigation conducted as part of the post-market clinical follow-up of ChitoCare® Medical, aimed to confirm safety and efficacy according to the requirements of Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, for the following indications: Gel - scars, conditions after dermatosurgical procedures, dermatitis, acne Spray - conditions after dermatosurgical procedures, dermatitis, acne
This description comes directly from the study's public registry record.
Craig Fraser, PhD · +354 846 1912 · craig@chitocare.com
Always discuss trial participation with your own doctor first.
| Dermatovenerology department, FN Motol | Prague, Czechia | Recruiting |
| Dermatology of Prof. Hercogova | Prague, Czechia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06850389